MAP3K5 and fatty liver disease: CASP8 and a FADD-like apoptosis regulator (CFLAR) disrupts the N-terminus-mediated dimerization of ASK1 and favors ASK1 degradation and prevents JNK activation and hepatic steatosis [85].